News & Articles

Introduction Kirsten rat sarcoma viral oncogene homolog (KRAS) is the most frequently mutated oncogenes in human cancer​ [1]. Mutations in...

Circular RNA: A type of therapeutic drug modality.  Circular RNA (circRNA) is a class of covalently closed, circular non-coding RNA...

KACTUS is thrilled to announce that our GMP-Grade Cas9 enzyme is playing a pivotal role in the development of Bioheng Therapeutics'...

Global Rise of Heart Failure Heart failure (HF) is a severe clinical syndrome with an estimated global prevalence of 1-3%...

Nucleic acid removal is an essential step in biologics production workflows. Our MaxNuclease™ enzyme is a non-specific endonuclease from Serratia...

On December 19, 2024, Omeros announced that its pivotal Phase 3 clinical trial of the MASP2 antibody Narsoplimab (OMS721) in...

Background The production of high-quality mRNA is critical for a wide range of applications, including gene therapy, vaccine development, and...

CD19 remains a hot target in immunotherapy, driving innovation across a range of diseases. This is evidenced by recent approvals...

The approval of Casgevy in the UK in December 2023, the first CRISPR gene editing drug, marked the era of...

Domain Antigens for Antibody Discovery & Screening The antibody drug development underwent rapid progress over the past decade, with almost...

Obesity is increasingly undermining human health. Obesity, a chronic metabolic disease, has significantly impacted the health and quality of life...

Rising Obesity Rates: A Global Threat Obesity, a chronic metabolic disease, has significantly impacted the health and quality of life...